Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Maybe Canadian government can step up for Theralase
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1221)
•••
Comment by CancerSlayeron Jul 02, 2024 3:48pm
192 Views
Post# 36115050

RE:RE:RE:RE:Maybe Canadian government can step up for Theralase

RE:RE:RE:RE:Maybe Canadian government can step up for Theralase
plantrader wrote: Advancing the tech as far as it is hasn't been recognized by the market yet though, has it? But the exchange and/or track record does seem to be getting factored in by the market? For tiny companies without well known backers or well known CEO/mgt, I think the market unfortunately tends to take interim successes for granted but penalize for anything possible. Seems to be a complicated set of factors & the stock price is the recipient or victim to it. If it ever moves, I think it could be quite explosive. But something needs to happen first to lend definitive credibility such as BTD as you said.



Yes, well said...a BTD should significantly soften any lingering scientific or company doubt.  I currently see this exchange/market as no more than a temporary bunker within which a BTD will open the escape hatch to proper funding, & subsequently, a proper exchange.  Expectations will certainly be running high...
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities